NCT03089983View on ClinicalTrials.gov

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings

NACompletedINTERVENTIONAL
Enrollment

1,702

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions
Opioid DependenceAddictionHIV/AIDSTuberculosisHepatitis
Interventions
DRUG

Methadone

Participants will receive daily or weekly doses of oral methadone.

DRUG

Isoniazid

Participants will be randomized to receive standard INH as TB treatment in prison for 26 weeks.

DRUG

Rifapentine

Participants will be randomized to receive short course INH + RIF as TB treatment in prison for 12 weeks.

Trial Locations (1)

Unknown

Kajang Prison, Kajang

All Listed Sponsors
collaborator

University of Malaya

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT03089983 - Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings | Biotech Hunter | Biotech Hunter